Abingworth is a leading life science investment firm with over 30 years of experience in supporting biopharma companies in the US and Europe. They specialize in turning breakthrough scientific discoveries into innovative medicines, providing the necessary capital, expertise, and guidance to their portfolio companies.
With a strong focus on early-stage investing, Abingworth has successfully invested in over a hundred young companies, helping them navigate the challenges of the biotech industry. Their transatlantic presence, with offices in London, Boston, and San Francisco, allows them to stay connected to the latest developments in the key biotech hubs on both sides of the Atlantic.
Generated from the website